Literature DB >> 20729457

The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.

Young-Sun Kim1, Won Jae Lee, Hyunchul Rhim, Hyo K Lim, Dongil Choi, Ji Young Lee.   

Abstract

OBJECTIVE: The aim of this study was to elucidate the minimal ablative margin for percutaneous radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) (> 2 and < 5 cm) needed to prevent local tumor progression using CT image fusion and a 3D quantitative method.
MATERIALS AND METHODS: From April 2005 to March 2007, we performed percutaneous RFA for the treatment of 382 HCCs larger than 2 cm and smaller than 5 cm. A total of 110 tumors in 103 patients (77 men and 26 women; mean age, 59.7 years) that were previously untreated and were monitored for at least 1 year were retrospectively enrolled. A 5-mm safety margin was attempted in all cases, and a CT finding of complete replacement of the index tumor by RFA zone was defined as technical success. We constructed fusion images of CT images obtained before and after RFA and performed radial multiplanar reformation with the rotation axis at the center of the tumor to analyze the ablative margin quantitatively. Risk factors for local tumor progression (the thinnest ablative margin, tumor size, and the effect of hepatic vessels) were assessed by multivariate analysis.
RESULTS: Patients underwent follow-up for 12.9-46.6 months (median, 28.1 months). The tumors were 2.1-4.8 cm (mean +/- SD, 2.7 +/- 0.6 cm) in diameter. The thinnest ablative margins ranged from 0 to 6 mm (1.0 +/- 1.4 mm). A 5-mm safety margin was achieved in only 2.7% (3/110) of cases. In 47.3% (52/110) of cases, vessel-induced indentation of the ablation zone contributed to the thinnest ablative margins. Local tumor progression was detected in 27.3% (30/110) of cases. Concordance between local tumor progression and the thinnest margin was observed in 83.3% (25/30) of cases. The incidence of concordant local tumor progression was 22.7% (25/110), 18.9% (10/53), 5.9% (2/34), and 0% (0/15) in tumors with the thinnest ablative margin of > or = 0, > or = 1, > or = 2, and > or = 3 mm, respectively. An insufficient ablative margin was the sole significant factor associated with local tumor progression.
CONCLUSION: When the thickness of the ablative margin is evaluated by CT image fusion, a margin of 3 mm or more appears to be associated with a lower rate of local tumor progression after percutaneous RFA of HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729457     DOI: 10.2214/AJR.09.2954

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  84 in total

1.  A comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases.

Authors:  Thomas J Vogl; Andrei Roman; Nour-Eldin A Nour-Eldin; Wolfgang Hohenforst-Schmidt; Iliana Bednarova; Benjamin Kaltenbach
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

2.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

Review 3.  Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Authors:  Elena Nadia Petre; Constantinos Sofocleous
Journal:  Visc Med       Date:  2017-02-03

4.  Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Takanori Ito; Yasuhiro Sone; Yuji Kaneoka; Atsuyuki Maeda; Seiji Okuda; Katsuhiko Otobe; Kenichi Takahashi
Journal:  Eur Radiol       Date:  2014-06-22       Impact factor: 5.315

5.  Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.

Authors:  Daniel I Glazer; Servet Tatli; Paul B Shyn; Mark G Vangel; Kemal Tuncali; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2017-09-27       Impact factor: 3.959

6.  Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.

Authors:  Xiao-Wan Bo; Hui-Xiong Xu; Le-Hang Guo; Li-Ping Sun; Xiao-Long Li; Chong-Ke Zhao; Ya-Ping He; Bo-Ji Liu; Dan-Dan Li; Kun Zhang; Dan Wang
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

7.  Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.

Authors:  Sireesha Yedururi; Silanath Terpenning; Sanjay Gupta; Patricia Fox; Sooyoung Shin Martin; Claudius Conrad; Evelyne M Loyer
Journal:  J Comput Assist Tomogr       Date:  2017 Jul/Aug       Impact factor: 1.826

8.  A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.

Authors:  Francois H Cornelis; Jeremy C Durack; Simon Y Kimm; Thomas Wimmer; Jonathan A Coleman; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Cardiovasc Intervent Radiol       Date:  2017-05-17       Impact factor: 2.740

9.  Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.

Authors:  Nicole Hijnen; Esther Kneepkens; Mariska de Smet; Sander Langereis; Edwin Heijman; Holger Grüll
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-31       Impact factor: 11.205

10.  Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes.

Authors:  Hiroki Nishikawa; Yukio Osaki; Eriko Iguchi; Haruhiko Takeda; Fumihiro Matsuda; Jun Nakajima; Azusa Sakamoto; Keiichi Hatamaru; Sumio Saito; Akihiro Nasu; Ryuichi Kita; Toru Kimura
Journal:  J Gastroenterol       Date:  2012-10-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.